Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB lowered its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 9.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 598,882 shares of the real estate investment trust's stock after selling 60,047 shares during the period. Handelsbanken Fonder AB owned 0.09% of Healthpeak Properties worth $12,109,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Douglas Lane & Associates LLC boosted its stake in shares of Healthpeak Properties by 8.5% during the first quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust's stock worth $56,471,000 after buying an additional 218,395 shares during the period. Ibex Wealth Advisors acquired a new stake in Healthpeak Properties during the 1st quarter worth approximately $5,056,000. Two Sigma Advisers LP acquired a new stake in Healthpeak Properties during the 4th quarter worth approximately $5,691,000. Wellington Management Group LLP lifted its holdings in shares of Healthpeak Properties by 122.8% during the fourth quarter. Wellington Management Group LLP now owns 155,777 shares of the real estate investment trust's stock worth $3,158,000 after purchasing an additional 85,867 shares during the period. Finally, Vert Asset Management LLC lifted its holdings in shares of Healthpeak Properties by 6.9% during the first quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust's stock worth $6,574,000 after purchasing an additional 20,924 shares during the period. Institutional investors and hedge funds own 93.57% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Evercore ISI decreased their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a report on Monday, April 28th. Robert W. Baird reduced their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. Wall Street Zen cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Thursday, May 1st. Scotiabank reduced their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research report on Monday, May 12th. Finally, Wedbush reduced their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $23.27.

Insider Transactions at Healthpeak Properties

In other news, Director Tommy G. Thompson acquired 5,777 shares of the business's stock in a transaction dated Wednesday, May 28th. The stock was acquired at an average price of $17.27 per share, with a total value of $99,768.79. Following the completion of the transaction, the director now directly owns 144,290 shares in the company, valued at approximately $2,491,888.30. This represents a 4.17% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Scott M. Brinker purchased 11,337 shares of the business's stock in a transaction on Monday, April 28th. The stock was acquired at an average price of $17.68 per share, with a total value of $200,438.16. Following the completion of the acquisition, the chief executive officer now directly owns 201,863 shares in the company, valued at $3,568,937.84. The trade was a 5.95% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 29,764 shares of company stock valued at $521,909 over the last three months. 0.23% of the stock is currently owned by insiders.

Healthpeak Properties Price Performance

DOC traded down $0.24 during midday trading on Monday, reaching $17.14. 5,170,698 shares of the company's stock were exchanged, compared to its average volume of 5,188,749. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The stock has a market capitalization of $11.91 billion, a PE ratio of 48.98, a P/E/G ratio of 2.17 and a beta of 1.04. The business's 50-day moving average price is $17.71 and its 200 day moving average price is $19.36. Healthpeak Properties, Inc. has a 1-year low of $16.64 and a 1-year high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The firm had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. During the same period in the previous year, the firm posted $0.45 EPS. The company's quarterly revenue was up 15.9% compared to the same quarter last year. As a group, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were issued a $0.1017 dividend. The ex-dividend date was Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties's dividend payout ratio (DPR) is 305.00%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.